Nottinghamshire, United Kingdom

Tom Fowler

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Receptos, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tom Fowler. Retrieved from https://idiyas.com/inventor/tom-fowler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tom Fowler

Introduction

Tom Fowler is an accomplished inventor based in Nottinghamshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on CXCR3 receptor agonists. His research and inventions have the potential to impact various therapeutic areas.

Latest Patents

Tom Fowler holds a patent for CXCR3 receptor agonists. The patent describes compounds that possess a specific structure defined in Formula I, where R, R, R, R, and R are as specified. Additionally, the patent includes pharmaceutical compositions comprising these compounds, along with methods related to their manufacture and use.

Career Highlights

Fowler is associated with Receptos, Inc., where he has been instrumental in advancing research and development in his area of expertise. His work has contributed to the understanding and potential treatment of diseases related to the CXCR3 receptor.

Collaborations

Tom Fowler has collaborated with notable colleagues, including Adam Richard Yeager and Philip Turnbull. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Tom Fowler's contributions to the field of pharmaceuticals through his patent on CXCR3 receptor agonists exemplify his dedication to innovation. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…